Gestation-specific reference intervals for thyroid hormones are used to estimate thyroid function in pregnant women. This study was to establish the reference intervals for pregnant women in Zhejiang province, China. A total of 9038 cases were recruited. The values of thyroid-stimulating hormone (TSH), free thyroxine, free triiodothyronine, total thyroxine, and total triiodothyronine were determined by Beckman Coulter DxI-800 analyzers. Our results indicated that the level of TSH declined in the first trimester and then rose as pregnancy progressed. Conversely, the level of free triiodothyronine rose in the first trimester and then declined. The ranges of free thyroxine kept the decreasing trend crossing the gestation period. For total triiodothyronine, the ranges increased as pregnancy progressed and declined in the third trimester. The variation trends of total triiodothyronine and total thyroxine were similar. Our data confirmed the importance of the reference intervals of thyroid hormones for pregnant women.
Currently, the reagents and analyzers from Europe or America are being used in many clinical chemistry laboratories in China. The corresponding reference intervals are more suitable for Americans, but probably lead to inaccurate diagnosis of maternal thyroid dysfunction in other populations. 8 In addition, GRIs may be various among different regions in China. Therefore, GRIs should be established to suit the analyzers and patients locally. 9 In this study, we set up gestation-specific reference intervals of thyroid hormones determined by Beckman Coulter DxI-800 analyzers for pregnant women in Zhejiang province in China.
Materials and Methods

Study Population
The current study was carried out in Zhejiang Provincial People's Hospital, Zhejiang province, China. The test result of thyroid function was collected from the people who visited the department of obstetrics and gynecology for prepregnancy physical examination or prenatal care from January 2015 to December 2016. According to the recommendations of the National Academy of Clinical Biochemistry (NACB), 10 the women who met 1 of the following selection criteria were excluded: 1) evidence for autoimmune thyroid disease or laboratory results of positive serum thyroid peroxidase or thyroglobulin antibodies (TPOAb >9 IU/mL or TgAb > 5 IU/mL), 2) chronic or other autoimmune disease (tumors, hypertension, diabetes, inflammatory bowel disease, or asthma), 3) multiple or complicated pregnancies (perinatal infections, stillbirths, gestational diabetes, hyperemesis, or hypertension).
Laboratory Measurements
For each sample, thyroid-stimulating hormone (TSH), free thyroxine (free T4), free triiodothyronine (free T3), total thyroxine (total T4), total triiodothyronine (total T3), TPOAb, and TgAb were measured using Beckman Coulter DxI-800 analyzers. Daily quality controls were performed and all measurements were controlled.
Statistical Analysis
The normal distribution of our data was checked using Kolmogorov-Smirnov test. If the data did not comply with the normal distribution, Box-Cox would be used to transform the data to a normal distribution. During analysis, the data out of the range (from lower limit to upper limit) were defined as outliers. The stem-and-leaf and box plots in SPSS statistical software were used to find and eliminate outliers. The interquartile range (IQR) between the lower and upper quartiles of the distribution was calculated by the software, and the formulas for the calculations of the lower limit and upper limit were as follows: lower limit = P25 − 3 × IQR; upper limit = P75 + 3 × IQR (P25: 25th percentile, P75: 75th percentile). Finally, nonparametric method was applied to calculate the median and 2.5th/97.5th percentiles. The reference intervals were established according to guideline in EP28-A3c. 11 All the results were analyzed by 
Results
In this study, a total of 10,005 participants were enrolled. Based on the exclusion criteria, 9038 Chinese women (including 2077 nonpregnant women and 6961 pregnant women) remained. All the participants were divided into 4 groups according to their gestational age ( Table 1) . Of them, 22.98% were in Group 1 (nonpregnant); 21.86% were in Group 2 (the first trimester, <13 weeks); 32.04% were in Group 3 (the second trimester, 13-27 weeks); 23.12% were in Group 4 (the third trimester, >27 weeks).
No normal distribution of the data for these thyroid hormones was found in the 4 groups. Therefore, the distributions of these data were transformed into normal distributions, and the outliers in each group were eliminated ( Table 1) . For TSH, free T4, free T3, total T4, and total T3, the significant differences among the 4 groups were observed. Their values were also significantly different between the 2 comparisons, except for the comparison between Group 1 and Group 4 for TSH and the comparison between Group 3 and Group 4 for total T4 ( Figure 1 ). The median, the 2.5th percentile, and the 97.5th percentile for every thyroid hormone crossing the entire pregnancy period were shown in Table 2 . Moreover, the variation trend of the reference interval of every thyroid hormone among the four groups was also shown in Figure  1 . Our results indicated that the reference interval of TSH declined in the first trimester, then rose as pregnancy progressed ( Table 2 and Figure 1A ). Conversely, the reference interval of free T3 rose in the first trimester, then declined as pregnancy progressed ( Table 2 and Figure 1C ). The reference interval of free T4 kept the decreasing trend crossing the whole gestation period ( Table 2 and Figure 1B ). For both total T3 and total T4, the reference intervals increased as pregnancy progressed. However, a decrease of total T3 in the third trimester was found. For total T4, no significant difference was observed between the second trimester and the third trimester ( Table 2 , Figures 1D, 1E ). 
Figure 1
The fluctuations of TSH, free T4, free T3, total T4, and total T3 during normal pregnancy. The variation trends of TSH (A), free T4 (B), free T3 (C), total T4 (D), and total T3 (E) during normal pregnancy. Group 1 contains nonpregnant women; Group 2 contains pregnant women in the first trimester (<13 weeks); Group 3 contains women in the second trimester (13-27 weeks); Group 4 contains women in the third trimester (>27 weeks). The significant difference between Groups 1 and 2, Groups 1 and 3, Groups 1 and 4, Groups 2 and 3, Groups 2 and 4, and Groups 3 and 4 is indicated by "a", "b", "c", "d", "e", and "f," respectively. 
Discussion
The alterations in the pituitary-thyroid axis will lead to the increases in the contents of total T3 and total T4, as well as serum thyroglobulin (TG), during pregnancy. The daily iodine requirement of pregnant woman will increase up to 150%, and iodine clearance in the kidney will be elevated. Meanwhile, the mild increase in the content of β-hCG may bring about negative feedback on TSH secretion, especially in the first trimester. It has been demonstrated that ethnicity, iodine status, geographic position, assays, and detection reagents could influence the establishment of GRIs, which are different from the reference values for nonpregnant women in normal population. [12] [13] [14] Ignoring these these factors will lead to 5.6%-18.3% misdiagnosis and mistreatment of thyroid diseases in clinic practice. 15 Therefore, the IFCC and ICSH recommend that the clinic laboratory in each hospital could establish the GRIs, which are suitable for the local population.
Until now, various GRIs have been established based on different assays or in different areas in China. In the current study, we first established the GRIs of thyroid hormones determined by Beckman Coulter DxI-800 analyzers in Zhejiang province.
As shown in Table 2 , a majority of the GRIs of thyroid hormones calculated by us were narrower than the reference limits of the manufacturer. Therefore, we could infer that the application of the reference intervals according to the manufacturer will easily lead to thyroid clinical misdiagnosis in pregnant women. Furthermore, the significant differences were also found in the reference intervals of thyroid hormones between pregnant and nonpregnant women. These results were consistent to several previous studies. [16] [17] [18] [19] Moreover, our results indicated that the reference intervals were different among the first trimester, the second trimester, and the third trimester. Our results confirmed the necessity of GRIs and also suggested us to avoid using the same GRIs in different periods during pregnancy.
To better learn the GRI changes, we compared our results to the data in several previous studies, which were based on different areas or assays ( Table 3) . In multiple indicators, TSH and free T4 were the most commonly used to check thyroid function. TSH ranges always increased from the first trimester to the third trimester. In contrast, free T4 ranges usually declined from the early to the late gestational stages. Although the changing trends in different studies were similar, the exact data were not the same. First, the TSH upper limits calculated in this study were higher than that in Caucasian populations. The upper limits also exceeded the threshold level (2.5 mIU/L) recommended by the American Thyroid Association (ATA). Second, a majority of GRIs of TSH and free T4 during different gestational stages in our study were lower than that in Chinese populations reported in other studies. Third, the GRI of TSH in the third trimester was still lower than that in the stage of prepregnancy in other studies, but no significant difference between the 2 stages was found in our study ( Figure 1E ). In our opinion, the different assays or regions might be the main cause for the various results among different studies. For instance, Shen et al established the GRIs for people in Zhejiang, but they used the ARCHITECT i2000SR Analyzer, which was different from ours. 16 Additionally, the GRIs based on Beckman Coulter
DxI analyzers were established in Zhang's study and Yu's study, but the populations enrolled in their study was different from ours. 17, 20 Finally, several limitations that existed in the current study had to be acknowledged. First, maternal iodine was not considered in our study. Second, the values of TSH and free T4 could not be determined serially in each participant, and the result might be affected by interindividual variation. Third, fasting was not essential for the women enrolled in our study, and that factor might influence our results. 21 In summary, we established the GRIs for estimation of thyroid function based on Beckman Coulter DxI-800 analyzers in Zhejiang province in China. Our data confirmed the importance of these specific reference intervals for pregnant women and they would be in favor of accurate detection of thyroid dysfunction during pregnancy. LM 
